Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Wittig

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|March 4, 1998
Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutationC A Schmitt, K R Thaler, B M Wittig, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 9, 2001
Human biliary mucin binds to E-selectin: a possible role in modulation of inflammationN Sreejayan, B M Wittig, N von Stillfried, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Elevated serum E-selectin in patients with liver metastases of colorectal cancerB M Wittig, H Kaulen, R Thees, et al.
International Journal of Cancer|July 3, 1996
alpha(1,3)Fucosyltransferase expression in E-selectin-mediated binding of gastrointestinal tumor cellsB M Wittig, R Thees, H Kaulen, et al.
Scandinavian Journal of Rheumatology|July 18, 2019
Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritisF Behrens, M Koehm, E C Schwaneck, et al.
Gut|February 13, 2004
An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivoA Stallmach, T Marth, B Weiss, et al.
Clinical and Experimental Immunology|October 20, 2005
Short-term treatment with anti-CD44v7 antibody, but not CD44v4, restores the gut mucosa in established chronic dextran sulphate sodium (DSS)-induced colitis in miceS Farkas, M Hornung, C Sattler, et al.
Experimental and Molecular Pathology|June 5, 2003
Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter regionA Stallmach, B M Wittig, K Kremp, et al.
Zeitschrift Fur Gastroenterologie|April 19, 2002
Expression of CD44v6 has no prognostic value in patients with colorectal cancerB Jüngling, M Menges, R Goebel, et al.
International Journal of Colorectal Disease|May 17, 2002
The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in miceK Pfister, B M Wittig, B Jüngling, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|March 4, 1998
Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutationC A Schmitt, K R Thaler, B M Wittig, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 9, 2001
Human biliary mucin binds to E-selectin: a possible role in modulation of inflammationN Sreejayan, B M Wittig, N von Stillfried, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Elevated serum E-selectin in patients with liver metastases of colorectal cancerB M Wittig, H Kaulen, R Thees, et al.
International Journal of Cancer|July 3, 1996
alpha(1,3)Fucosyltransferase expression in E-selectin-mediated binding of gastrointestinal tumor cellsB M Wittig, R Thees, H Kaulen, et al.
Scandinavian Journal of Rheumatology|July 18, 2019
Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritisF Behrens, M Koehm, E C Schwaneck, et al.
Gut|February 13, 2004
An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivoA Stallmach, T Marth, B Weiss, et al.
Clinical and Experimental Immunology|October 20, 2005
Short-term treatment with anti-CD44v7 antibody, but not CD44v4, restores the gut mucosa in established chronic dextran sulphate sodium (DSS)-induced colitis in miceS Farkas, M Hornung, C Sattler, et al.
Experimental and Molecular Pathology|June 5, 2003
Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter regionA Stallmach, B M Wittig, K Kremp, et al.
Zeitschrift Fur Gastroenterologie|April 19, 2002
Expression of CD44v6 has no prognostic value in patients with colorectal cancerB Jüngling, M Menges, R Goebel, et al.
International Journal of Colorectal Disease|May 17, 2002
The in vitro anti-inflammatory effects of recombinant anti-CD25 immunotoxin on lamina propria T cells of patients with inflammatory bowel disease are not sufficient to cure experimental colitis in miceK Pfister, B M Wittig, B Jüngling, et al.
Pageof 4